While amyloid imaging is typically discussed with regard to diagnosing Alzheimer’s disease, a team of French researchers, presenting at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 annual meeting, have found that amyloid scans of the heart can predict major cardiac events.

At the American Society of Echocardiography (ASE) annual scientific sessions, the use of point-of-care echocardiography is among the major topics of discussion. The conference takes place from June 12 to June 16 at the Hynes Convention Center in Boston.

Thoratec Corporation, a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced that the FDA has granted conditional approval for a U.S. IDE clinical trial to investigate use of the HeartMate PHP acute catheter-based heart pump in patients undergoing a high-risk percutaneous coronary intervention.

Listen to Dr. Mani Vannan of Piedmont Heart Institute in Atlanta for a discussion on 3D transesophageal echocardiography. It's quick, just 12 minutes, and sure to make you want to take a closer look at 3D TEE.

Are Riata concerns a thing of the past and transcatheter aortic valve replacement (TAVR) for almost anyone with severe aortic stenosis the way of the future? Presentations at recent cardiology conferences addressed those questions.

Echocardiography pioneer Borys Surawicz, MD, who served as president of the American College of Cardiology (ACC) from 1979 to 1980, has died, the ACC announced on its blog.

Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery in low-risk patients with severe aortic stenosis, based on two-year results presented May 19 at EuroPCR in Paris.

A panel of experts recommended that remote monitoring become the standard of care for patients with cardiovascular implantable electronic devices (CIEDs), according to a consensus statement from the Heart Rhythm Society (HRS). The statement was published online in Heart Rhythm on May 13.